Insights on pharma trends and real-world AI applications in life sciences
Incyte has announced a strategic partnership with Edison Scientific to integrate their AI platform, Kosmos, across Incyte’s drug discovery and development processes. Unlike common AI tools that function primarily as "auxiliary analysis" aids, this collaboration aims to establish a "continuous feedback and learning" model, positioning experimental data as a "compounding asset."
On April 7, Pharmato's AI Knowledge Base received an update. Everyone is welcome to use it.
Pharmato Integras launches its free version, using AI to greatly improve new drug research efficiency. It includes Pipeline Merger, which integrates and cleans multi-database data to build complete competitive intelligence, and PosterLens, which extracts, interprets and compares clinical conference Poster data intelligently. Users can register for free on its official website to access these core tools.
This article points out that relying on a single commercial database leads to incomplete new drug competitive intelligence, as shown in a small‑cell lung cancer study where no database covered all 1,341 pipelines, with coverage only 36%–57%. Gaps stem from differing data sources, update methods, and inclusion rules. Merging 2–3 databases is ideal but requires heavy manual cleaning. The AI tool Yaofanqie Integras automates field matching and deduplication, cutting pipeline integration from days to minutes.
5 min